Resources

To best optimize available malaria funding, countries and programs have to make evidence-based decisions implementing malaria control interventions, including new vector control tools. This study aims to describe the malaria control decision-making landscape in Mali and Zambia and assess the facilitators and barriers that affect evidence generation and utilization.

Eliminating malaria requires collaboration across borders, sectors, and disciplines. PATH engages partners in the public, private, and nonprofit sectors to develop, evaluate, and scale tools and strategies to defeat malaria. Our partnership model translates bold ideas into products and strategies, and leverages national capacity in the fight against malaria.

PATH lays out recommendations for the US Administration and Congress to accelerate progress toward a malaria-free world. By fully funding malaria programs, intensifying support for research and development, and leveraging US influence globally, the United States can take a decisive step toward eradicating malaria and a healthier future for all.

This brochure outlines PATH's work in Senegal. It describes our approach and outlines key areas of focus, including malaria elimination, strengthening health systems, responding to emerging health threats, improving reproductive health, and combatting noncommunicable diseases.

This poster demonstrates that the use of DHAp for malaria treatment was generally safe and well tolerated. A total of 687 adverse events (AEs) were reported (0.13% of participants, 0.24% of treatments). Four AEs were initially reported as serious adverse events, though three were later identified as not related to drug ingestion.